Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Yang-Hyun Baek

Clin Mol Hepatol. 2025;31(1):319-322. Published online October 7, 2024

DOI: https://doi.org/10.3350/cmh.2024.0856

View: 1184 Download: 33 Web of Science: 2 Crossref: 2

Mengyao Yan, Shuli Man, Long Ma, Lanping Guo, Luqi Huang, Wenyuan Gao

Clin Mol Hepatol. 2024;30(4):620-648. Published online July 11, 2024

DOI: https://doi.org/10.3350/cmh.2024.0315

View: 4454 Download: 283 Web of Science: 10 Crossref: 10

Erica Jennison, Christopher D. Byrne

Clin Mol Hepatol. 2021;27(1):22-43. Published online December 10, 2020

DOI: https://doi.org/10.3350/cmh.2020.0129

View: 12040 Download: 458 Web of Science: 59 Crossref: 64

Special topic: Alcoholic liver diseases The 14th International Symposium on Alcoholic Liver and Pancreatic Diseases and Cirrhosis (ISALPDC)

Beatriz Garcia Mendes, Bernd Schnabl

Clin Mol Hepatol. 2020;26(4):595-605. Published online September 11, 2020

DOI: https://doi.org/10.3350/cmh.2020.0086

View: 9857 Download: 253 Web of Science: 30 Crossref: 35

1 |

Viewed By 11947	Epidemiology of metabolic dysfunction-associated steatotic liver disease
Viewed By 7478	MAFLD: How is it different from NAFLD?
Viewed By 6568	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 5734	Hepatocellular carcinoma: updates on epidemiology, surveillance, diagnosis and treatment
Viewed By 5352	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 355	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 331	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 223	MAFLD: How is it different from NAFLD?
Cited By 114	Non-alcoholic fatty liver disease: Definition and subtypes
Cited By 110	Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis

Search